GlassScriptPhysician profile
Nitin Rangnekar
NPI 1225089550
$34,899.04
in general payments reported to CMS, 2019-2025
24 companies · $2,999 in 2025
The $2,999 reported for 2025 was more than what 86% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,077 · 2020: $9,472 · 2021: $147 · 2022: $3,184 · 2023: $6,330 · 2024: $3,690 · 2025: $2,999.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $9,000 · Food and Beverage: $2,104 · Travel and Lodging: $1,907 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $9,000.00 |
| Food and Beverage | $2,103.75 |
| Travel and Lodging | $1,906.56 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $31,922.35 | 2019-2025 | Davinci Xi |
| Boston Scientific Corporation | $2,015.48 | 2019-2025 | Overstitch Endoscopic Suturing System, Apollo Esg Nxt System, Compliance Endokit |
| Acera Surgical, INC. | $158.35 | 2024-2025 | Restrata Wound Matrix |
| Medtronic, INC. | $101.11 | 2023-2024 | Absorbatack, Progrip, Interstim |
| Conmed Corporation | $96.35 | 2023 | Airseal |
| Tela Bio, INC. | $54.21 | 2020-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Covidien LP | $53.69 | 2019-2020 | |
| Davol INC. | $45.73 | 2024 | Phasix Mesh |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $43.93 | 2023-2024 | Xifaxan |
| Acell, INC. | $37.31 | 2019-2020 | |
| Mimedx Group, INC. | $36.42 | 2025 | |
| Ambu INC. | $35.37 | 2020-2023 | |
| Sanara Medtech INC. | $32.69 | 2022-2023 | Celleraterx |
| Axonics, INC. | $32.41 | 2023 | Axonics |
| Elucent Medical | $29.98 | 2025 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $29.67 | 2025 | Perclot |
| Abbvie INC. | $28.80 | 2023 | |
| Portola Pharmaceuticals, LLC | $28.24 | 2019 | |
| Olympus America INC. | $24.36 | 2019 | |
| Shire North American Group INC | $24.36 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $23.32 | 2021 | |
| Capsovision, INC. | $16.91 | 2024 | Capsocam Plus |
| Janssen Biotech, INC. | $14.14 | 2023 | Simponi Aria, Remicade, Simponi |
| Teleflex LLC | $13.86 | 2024 | Deknatel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nitin Rangnekar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.